Cyclophosphamide 1 GM vials
Ended Awarded Last action
- Contract number
- SPE2DR26FXR4G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,161
Award facts
- Contract value 100% obligated
- $5,160.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,160.60 delivery order to AmerisourceBergen Drug Corp for the procurement of Cyclophosphamide 1 GM vials, with an ultimate completion date of January 20, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded on a full and open basis. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Cyclophosphamide is a critical chemotherapy medication used in oncology and immunosuppressive treatment protocols across military healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's long-standing relationship with DLA, evidenced by its substantial prime vendor contract, positions it as a reliable supplier of specialized pharmaceutical commodities, including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FXR4G?
SPE2DR26FXR4G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FXR4G worth?
The government has obligated $5,161 on SPE2DR26FXR4G.
Is contract SPE2DR26FXR4G an order under another contract?
Yes. SPE2DR26FXR4G is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR4G competed?
The extent of competition for SPE2DR26FXR4G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award